Article Details

FDA accepts application for nirsevimab against RSV in infants - Contemporary Pediatrics

Retrieved on: 2023-01-05 19:22:43

Tags for this article:

Click the tags to see associated articles and topics

FDA accepts application for nirsevimab against RSV in infants - Contemporary Pediatrics. View article details on hiswai:

Excerpt

Protection is timely, direct, and rapid, as the immune system does not need to activate for monoclonal antibodies to function.

Article found on: www.contemporarypediatrics.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up